Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LI.d

Myocarditis (can be fulminant)

Publications

Cesa K, Cunningham C, Harris T, Sunseri W

A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease.

Cureus 2022 Jun;14;e26366 — 2022 Jun — e26366

Song HY, Seo GS

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2022 Jan 25;79;31-34 — 2022 Jan 25 — 31-34

Ali A, Kumaravel Kanagavelu AS, Rahimi A, Mehmood Z, Tariq AB, Das T, Elmdaah A

A Rare Case of Mesalazine-Induced Acute Myocarditis in a 19-Year-Old Female With Ulcerative Colitis.

Cureus 2021 Nov;13;e20036 — 2021 Nov — e20036

Taha ME, Abdalla A, Al-Khafaji J, Malik S

Mesalamine-Induced Myopericarditis: A Case Report and Literature Review.

Cardiology research 2019 Feb;10;59-62 — 2019 Feb — 59-62

Dias T, Santos A, Santos RM, Carvalho A

Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.

BMJ case reports 2019 Feb 01;12; — 2019 Feb 01

Tagawa M, Nakamura Y, Okura Y, Nanba H, Kishi K, Akashi E, Ochiai Y, Asai Y, Chinushi M

Successful Treatment of Acute Fulminant Eosinophilic Myocarditis in a Patient with Ulcerative Colitis Using Steroid Therapy and Percutaneous Cardiopulmonary Support.

Internal medicine (Tokyo, Japan) 2019 Apr 15;58;1111-1118 — 2019 Apr 15 — 1111-1118

Okoro KU, Roby MD, Bankole AA

Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis.

Case reports in medicine 2018;2018;9813893 — 2018 — 9813893

Park EH, Kim BJ, Huh JK, Jeong EH, Lee SH, Bang KB, Seol JS, Sung JW, Kim BS, Kang JH

Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.

Journal of cardiovascular ultrasound 2012 Sep;20;154-6 — 2012 Sep — 154-6

Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H

Mesalazine-induced myopericarditis in a patient with ulcerative colitis.

International journal of colorectal disease 2006 Mar;21;199-200 — 2006 Mar — 199-200

Marteau P, Nelet F, Le Lu M, Devaux C

Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France.

Alimentary pharmacology & therapeutics 1996 Dec;10;949-56 — 1996 Dec — 949-56

Camus P, Piard F, Ashcroft T, Gal AA, Colby TV

The lung in inflammatory bowel disease.

Medicine 1993 May;72;151-83 — 1993 May — 151-83

Ariza A, López MD, Mate JL, Curós A, Villagrasa M, Navas-Palacios JJ

Giant cell myocarditis: monocytic immunophenotype of giant cells in a case associated with ulcerative colitis.

Human pathology 1995 Jan;26;121-3 — 1995 Jan — 121-3

Kristensen KS, Høegholm A, Bohr L, Friis S

Fatal myocarditis associated with mesalazine.

Lancet (London, England) 1990 Mar 10;335;605 — 1990 Mar 10 — 605